Early detection of preeclampsia.

Accuracy of mean arterial pressure and blood pressure measurements in predicting pre-eclampsia: systematic review and meta-analysis. BMJ (2008) 1.53

Early detection of preeclampsia. Am J Obstet Gynecol (1992) 0.75

Uric acid: is it time to give up routine testing in management of pre-eclampsia? Obstet Med (2012) 0.75

Is there a link among thrombophilia factors and preeclampsia? J Thromb Thrombolysis (2017) 0.75

Trial of calcium to prevent preeclampsia. N Engl J Med (1997) 3.69

Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med (1993) 2.96

Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol (1998) 2.72

Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol (1986) 2.41

The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens (2014) 2.29

No evidence for lipid peroxidation in severe preeclampsia. Am J Obstet Gynecol (2001) 2.28

Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med (2001) 2.23

Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in pregnancy: review of 11 cases. Am J Obstet Gynecol (1996) 2.22

Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol (1986) 2.21

Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol (1996) 1.94

The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol (1998) 1.81

Safety of labor epidural anesthesia for women with severe hypertensive disease. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol (1999) 1.75

Neonatal outcome after preterm delivery for preeclampsia. Am J Obstet Gynecol (1995) 1.73

Induction versus expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. Am J Obstet Gynecol (1993) 1.69

Predictors of neonatal outcome in women with severe preeclampsia or eclampsia between 24 and 33 weeks' gestation. Am J Obstet Gynecol (2000) 1.61

Accuracy of self-reported cigarette smoking among pregnant women in the 1990s. Paediatr Perinat Epidemiol (2001) 1.61

Dietary consumption and plasma concentrations of vitamin E in pregnancies complicated by preeclampsia. Am J Obstet Gynecol (1996) 1.59

The importance of urinary protein excretion during conservative management of severe preeclampsia. Am J Obstet Gynecol (1996) 1.57

Eclampsia. VIII. Risk factors for maternal morbidity. Am J Obstet Gynecol (2000) 1.50

The effect of magnesium sulfate therapy on the duration of labor in women with mild preeclampsia at term: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol (1997) 1.50

Clinical significance of elevated mean arterial blood pressure in second trimester and threshold increase in systolic or diastolic blood pressure during third trimester. Am J Obstet Gynecol (1989) 1.49

Hepatic histopathologic condition does not correlate with laboratory abnormalities in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count) Am J Obstet Gynecol (1992) 1.49

Recurrent acute fatty liver of pregnancy. Am J Obstet Gynecol (1990) 1.48

Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia. Am J Obstet Gynecol (2001) 1.48

Reassessment of intravenous MgSO4 therapy in preeclampsia-eclampsia. Obstet Gynecol (1981) 1.48

Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol (2000) 1.38

Antibiotic use in pregnancy and drug-resistant infant sepsis. Am J Obstet Gynecol (1999) 1.35

Pulmonary edema in severe preeclampsia-eclampsia: analysis of thirty-seven consecutive cases. Am J Obstet Gynecol (1987) 1.32

Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. Am J Obstet Gynecol (2000) 1.30

Late postpartum eclampsia revisited. Obstet Gynecol (1994) 1.30

Mild gestational hypertension remote from term: progression and outcome. Am J Obstet Gynecol (2001) 1.29

Eclampsia. V. The incidence of nonpreventable eclampsia. Am J Obstet Gynecol (1986) 1.29

Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol (2001) 1.19

Pregnancy outcome in 211 patients with mild chronic hypertension. Obstet Gynecol (1983) 1.16

Acute fatty liver of pregnancy: an experience in the diagnosis and management of fourteen cases. Am J Obstet Gynecol (1994) 1.16

Postpartum ovarian vein thrombosis after vaginal delivery: a report of 11 cases. Obstet Gynecol (1995) 1.15

Treatment in an obstetric intensive care unit. Am J Obstet Gynecol (1990) 1.15

Postpartum stroke: a twenty-year experience. Am J Obstet Gynecol (2000) 1.13

Effects of diuretics on plasma volume in pregnancies with long-term hypertension. Am J Obstet Gynecol (1984) 1.10

A longitudinal study of cardiac output in normal human pregnancy. Am J Obstet Gynecol (1994) 1.10

Maternal plasma level of endothelin is increased in preeclampsia. Am J Obstet Gynecol (1991) 1.09

An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol (2000) 1.09

Erythromycin therapy in preterm premature rupture of the membranes: a prospective, randomized trial of 220 patients. Am J Obstet Gynecol (1992) 1.09

Peripartum cardiomyopathy: an ominous diagnosis. Am J Obstet Gynecol (1997) 1.09

Urinary dipstick protein: a poor predictor of absent or severe proteinuria. Am J Obstet Gynecol (1994) 1.08

Trial of Calcium for Preeclampsia Prevention (CPEP): rationale, design, and methods. Control Clin Trials (1996) 1.07

Management of mild chronic hypertension during pregnancy: a review. Obstet Gynecol (2000) 1.06

Controlled cord traction versus minimal intervention techniques in delivery of the placenta: a randomized controlled trial. Am J Obstet Gynecol (1997) 1.04

Sacroiliitis associated with pyelonephritis in pregnancy. Obstet Gynecol (1995) 1.03

Hypertension in pregnancy: current concepts of preeclampsia. Annu Rev Med (1997) 1.03

The incidence of positive amniotic fluid cultures in patients preterm labor with intact membranes. Am J Obstet Gynecol (1989) 1.03

Maternal and perinatal outcome of expectant management of premature rupture of membranes in the midtrimester. Am J Obstet Gynecol (1988) 1.02

Fetal supraventricular tachycardia: in utero therapy with digoxin and quinidine. Obstet Gynecol (1984) 0.99

Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter? Am J Obstet Gynecol (1999) 0.99

Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet Gynecol (1998) 0.99

Inaccuracy of Dubowitz gestational age in low birth weight infants. Obstet Gynecol (1984) 0.98

A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term. Obstet Gynecol (1987) 0.98

The impact of initiating a human immunodeficiency virus screening program in an urban obstetric population. Am J Obstet Gynecol (1995) 0.98

A randomized, controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. Am J Obstet Gynecol (1998) 0.97

Risk factors for abruptio placentae and eclampsia: analysis of 445 consecutively managed women with severe preeclampsia and eclampsia. Am J Obstet Gynecol (1999) 0.96

Outcome after successful resuscitation of babies born with apgar scores of 0 at both 1 and 5 minutes. Am J Obstet Gynecol (2000) 0.95

Biochemical corroboration of endothelial involvement in severe preeclampsia. Am J Obstet Gynecol (1995) 0.95

Chronic hypertension in pregnancy. Minerva Ginecol (2003) 0.95

Cerebrovascular disorders complicating pregnancy--beyond eclampsia. Am J Obstet Gynecol (1997) 0.94

Eclampsia. I. Observations from 67 recent cases. Obstet Gynecol (1981) 0.93

Oral nifedipine pharmacokinetics in pregnancy-induced hypertension. Pharmacotherapy (1992) 0.93

The immunology of preeclampsia. Semin Perinatol (1999) 0.93

HELLP syndrome. Clin Obstet Gynecol (1999) 0.93

Evaluation of two rapid group B streptococcal antigen tests in labor and delivery patients. Obstet Gynecol (1991) 0.93

Cardiopulmonary arrest due to acute maternal hypermagnesaemia. Lancet (1981) 0.92

The accuracy and patient preference for self-collected group B Streptococcus cultures. Am J Obstet Gynecol (1995) 0.92

Fetal lung maturity is not accelerated in preeclamptic pregnancies. Am J Obstet Gynecol (1993) 0.92

A randomized comparison of oral misoprostol versus Foley catheter and oxytocin for induction of labor at term. Am J Obstet Gynecol (1999) 0.91

Management of chronic hypertension during pregnancy. Evid Rep Technol Assess (Summ) (2000) 0.91

The renin-angiotensin-aldosterone system in preeclampsia. A review. Clin Perinatol (1991) 0.91

Adult respiratory distress syndrome in pregnancy. Am J Obstet Gynecol (1992) 0.91

Clinical significance of elevated mean arterial pressure in the second trimester. Am J Obstet Gynecol (1988) 0.91

Pregnancy outcome of intensive therapy in severe hypertension in first trimester. Obstet Gynecol (1986) 0.91

Ultrastructural aspects of preeclampsia. I. Placental bed and uterine boundary vessels. Am J Obstet Gynecol (1989) 0.91

Labetalol pharmacokinetics in pregnancy-induced hypertension. Am J Obstet Gynecol (1990) 0.91

Relationship of hypertensive disease to abruptio placentae. Obstet Gynecol (1984) 0.90

The use of labetalol for attenuation of the hypertensive response to endotracheal intubation in preeclampsia. Am J Obstet Gynecol (1988) 0.90

Ampicillin prophylaxis in preterm premature rupture of the membranes: a prospective randomized study. Am J Obstet Gynecol (1988) 0.89

HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome versus severe preeclampsia: onset at < or =28.0 weeks' gestation. Am J Obstet Gynecol (2000) 0.89

A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol (1987) 0.89

Surgical treatment of uterine atony employing the B-Lynch technique. J Matern Fetal Med (2000) 0.89

Septic pelvic thrombophlebitis or refractory postpartum fever of undetermined etiology. J Matern Fetal Med (1997) 0.89

Current obstetrical practice and umbilical cord prolapse. Am J Perinatol (1999) 0.89

Ultrastructural aspects of preeclampsia. II. Mitochondrial changes. Am J Obstet Gynecol (1990) 0.88

Maternal-fetal correlations in patients with severe preeclampsia/eclampsia. Obstet Gynecol (1983) 0.88

Pregnancy outcome in 303 cases with severe preeclampsia. Obstet Gynecol (1984) 0.88

Nutrient intake and hypertensive disorders of pregnancy: Evidence from a large prospective cohort. Am J Obstet Gynecol (2001) 0.86

Pulmonary edema associated with pregnancy: echocardiographic insights and implications for treatment. Obstet Gynecol (1993) 0.86

Oral terbutaline after parenteral tocolysis: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol (1996) 0.86

A comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsia. Am J Obstet Gynecol (1984) 0.85

Biventricular assist device as a bridge to cardiac transplantation in the treatment of peripartum cardiomyopathy. South Med J (1997) 0.85

Correlation between bleeding times and platelet counts in women with preeclampsia undergoing cesarean section. Anesthesiology (1989) 0.85

Chronic hypertension in pregnancy. Obstet Gynecol Clin North Am (2001) 0.85

A comparison of various routes and dosages of misoprostol for cervical ripening and the induction of labor. Am J Obstet Gynecol (2001) 0.85

Plasma, urinary, and salivary 8-epi-prostaglandin f2alpha levels in normotensive and preeclamptic pregnancies. Am J Obstet Gynecol (2000) 0.85